Health Care: Drugs

Novavax Inc (NVAX: NASDAQ)

$9 0.16 | 1.81%
05/29/15 - 04:00 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 30.66M 20.92M 22.08M 14.69M
Cost of Sales 10.15M 5.12M 13.04M 5.07M
Gross Operating Profit 20.51M 15.79M 9.03M 9.62M
Selling, General, and Administrative Expenses 19.93M 14.82M 10.99M 11.38M
Research & Development 79.44M 50.31M 26.06M 17.88M
Operating Income before D & A (EBITDA) -78.85M -49.34M -28.02M -19.65M
Depreciation & Amortization 4.84M 3.10M 1.65M 1.93M
Interest Income 286.00K 187.00K 165.00K 136.00K
Other Income - Net 615.00K 449.00K 1.02M 2.50M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -82.79M -51.80M -28.48M -18.94M
Interest Expense 157.00K 160.00K 32.00K 9.00K
Pre-Tax Income -82.95M -51.96M -28.51M -18.95M
Income Taxes 0.00 25.00K 0.00 412.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -82.95M -51.98M -28.51M -19.36M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -82.95M -51.98M -28.51M -19.36M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -82.95M -51.98M -28.51M -19.36M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-82.95M -51.98M -28.51M -19.36M
Preferred Dividends
Net Income Available To Common -82.95M -51.98M -28.51M -19.36M
Basic EPS from Continuing Ops. -0.37 -0.31 -0.22 -0.17
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.37 -0.31 -0.22 -0.17
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.37 -0.31 -0.22 -0.17
Basic Normalized Net Income/Share -0.37 -0.31 -0.22 -0.17
EPS fr Continuing Ops. -0.37 -0.31 -0.22 -0.17
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.37 -0.31 -0.22 -0.17
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.37 -0.31 -0.22 -0.17
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.37 -0.31 -0.22 -0.17
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with NVAX

Latest NVAX Headlines from TheStreet

More Financial News for NVAX

Press Releases for NVAX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter